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779 1990 62 2,08 RT+HT HT Positive Negative
351 2000 48 4,07 RT+HT RT+HT Positive Positive
941 1997 63 1,03 CT HT Negative Positive
683 2002 77 1,86 NT HT Negative Positive
621 1985 62 1,79 2,15 RT NT Positive Positive
354 * 1992 39 3,39 0,28 RT+CT+HT HT Negative Unknown
177 * 1983 42 1,42 2,30 RT RT+CT Negative Negative
409 1999 37 2,47 RT+CT+HT RT+CT+HT Positive Negative
886 2003 71 1,53 1,40 RT HT Negative Positive
168 * 1994 51 2,91 2,59 RT+CT RT+CT+HT Negative Negative
806 2000 71 4,41 HT HT Positive Positive
169 1987 51 1,28 3,13 RT+CT HT Negative Positive
742 1989 62 4,50 7,99 NT NT Positive Unknown
3029 2001 51 4,78 RT+CT+HT CT Positive Negative
209 1991 46 4,21 HT NT Negative Positive
198 1999 55 4,85 RT+CT+HT CT Positive Negative
126 2000 58 4,74 RT RT+HT Positive Positive
3030 1996 45 0,41 3,51 NT RT+CT Negative Negative
639 1985 61 3,53 HT NT Negative Negative
340 2001 50 3,13 RT+CT RT+HT Negative Positive
919 1998 65 4,59 RT+CT RT+HT Negative Positive
30276 1981 74 4,90 1,74 RT+HT HT Positive Negative
383 1987 31 0,65 RT RT+CT Positive Positive
275 1990 43 3,91 NT CT+HT Positive Positive
404 1998 39 2,68 2,40 CT+HT RT+CT+HT Positive Negative
Mean 54,16 3,01 2,75
